TITLE

Effects of Sentinel Lymph Node Biopsy on Surgical Residency Training

AUTHOR(S)
Shin, Susanna; Fournier, Keith; Cole, Frederick; Laronga, Christine
PUB. DATE
September 2006
SOURCE
American Surgeon;Sep2006, Vol. 72 Issue 9, p791
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Axillary node dissection (AND) is an integral part of surgical training. Sentinel lymph node biopsy (SLN) was introduced into our residency in 1997. Our purpose in this study was to evaluate the impact of SLN on AND experience. AND/SLN operative experience of residents and attendings at our residency was reviewed using resident case-logs and questionnaires from 2002 and 2005. The perception of performing and teaching AND was assessed. Thirty-three residents and 24 attendings participated. Graduating chiefs from the class of 2000 performed no SLN, which increased to 4.25 in 2002 and to 8.5 in 2005. In contrast, graduating chiefs performed 25 AND in 2000, which decreased to 16.5 in 2002 and to 13.25 in 2005. The majority of the residents felt that AND was a senior level case (56% postgraduate year [PGY] 1 and I1 and 87% PGY lit-V). The majority of the residents felt that SLN was a junior level case (89% PGY I and II and PGY III-V). Fifty-six per cent of PGY III-V felt that SLN introduction negatively impacted their ability to perform AND. Attendings cited 15 and 24 AND before feeling comfortable performing and teaching the procedure to a resident. Since the introduction of SLN into our residency, the number of AND has decreased, with senior residents feeling that SLN has decreased their ability to perform AND. As fewer AND are performed than our attendings cite to feel comfortable, future residents may not be competent to perform or teach AND.
ACCESSION #
22234705

 

Related Articles

  • Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging? Meiers, Pamela; Cil, Tulin; Guller, Ulrich; Zuber, Markus // Langenbeck's Archives of Surgery;Jun2013, Vol. 398 Issue 5, p687 

    Purpose: The objective of this review is to summarize the evidence demonstrating that the sentinel lymph node (SLN) procedure is not only associated with significantly less morbidity compared to the axillary dissection, but may also result in better staging and improved patient outcomes....

  • Regional Differences in the Use of Sentinel Lymph Node Biopsy for Melanoma: A Potential Quality Measure. LANE, KAREN; KEMPF, ASHLEY; MAGNO, CHERYL; LANE, JOHN; BUTLER, JOHN; HSIANG, DAVID; GREENFIELD, SHELDON; JAKOWATZ, JAMES // American Surgeon;Oct2008, Vol. 74 Issue 10, p981 

    Sentinel lymph node biopsy (SLNB) provides accurate nodal staging in patients with melanoma. However, its prevalence across geographic regions is unknown. Our aim was to determine if SLNB for melanoma has been widely adopted throughout the United States. All patients in the Surveillance,...

  • Sentinel Lymph-Node Biopsy in Breast Cancer[*]. McCready, David R.; Bodurtha, Audley J.; Davis, Noelle L.; Meterissian, Sarkis; Robert, Jean; Temple, Walley J. // Canadian Journal of Surgery;Dec99, Vol. 42 Issue 6, p406 

    Focuses on the interest in sentinel lymph-node (SLN) biopsy in breast cancer. Details on Health Canada's `Clinical practice guidelines for the care and treatment of breast cancer'; Benefits of axillary dissection; Downside of axillary dissection; Stand of the Canadian Society of Surgical...

  • You Be the Coder.  // General Surgery Coding Alert;Apr2010, Vol. 12 Issue 4, p27 

    The article offers information on the importance of separately coding the sentinel lymph node biopsy through appropriate coding.

  • The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging. Kużdżał, Jarosław; Zieliński, Marcin; Papla, Bolesław; Urbanik, Andrzej; Wojciechowski, Wadim; Narski, Maciej; Szlubowski, Artur; Hauer, Łukasz // European Journal of Cardio-Thoracic Surgery;Jan2007, Vol. 31 Issue 1, p88 

    Abstract: Objective: To compare the diagnostic yield of the transcervical extended mediastinal lymphadenectomy (TEMLA) and the cervical mediastinoscopy (CM) in detecting metastatic mediastinal lymph nodes in NSCLC patients. Methods: Prospective, randomized, single-blind clinical study. Results:...

  • Surgical Management of the Axilla in Breast Cancer. MASTRANGELO, STEPHANIE; McMASTERS, KELLY; AJKAY, NICOLAS // American Surgeon;Jun2016, Vol. 82 Issue 6, p475 

    This article offers a review of the literature on current surgical management of the axilla in breast cancer. This includes the decision-making process involved in clinically node-negative patients versus clinically node-positive patients, with discussion of the indications for sentinel lymph...

  • Sequential Dermal-Peritumoral Radiocolloid Injection for Sentinel Node Biopsy for Breast Cancer: The University of Florida Experience. Feezor, Robert J.; Kasraeian, Ali; Copeland III, Edward M.; Schell, Scott R.; Hochwald, Steven N.; Cendan, Juan; Drane, Walter; Mastin, Suzanne; Wilkinson, Edward; Lind, D. Scott // American Surgeon;Aug2002, Vol. 68 Issue 8, p684 

    Although sentinel lymph node (SLN) biopsy is rapidly becoming the standard of care for small breast cancers the optimal radiocolloid injection technique remains controversial. We report our experience with sequential dermal-peritumoral radiocolloid injection that takes advantage of both...

  • Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer. Gentilini, Oreste; Chagas, Eduardo; Zurrida, Stefano; Intra, Mattia; De Cicco, Concetta; Gatti, Giovanna; Silva, Luzemira; Renne, Giuseppe; Cassano, Enrico; Veronesia, Umberto // Oncologist;May2007, Vol. 12 Issue 5, p512 

    Mastectomy with axillary dissection is still the most commonly recommended procedure for male breast cancer. The aim of this study was to retrospectively evaluate our experience in 32 male patients with early breast cancer who underwent sentinel lymph node biopsy (SLNB) and axillary dissection...

  • Correlation Between Clinical Nodal Status and Sentinel Lymph Node Biopsy False Negative Rate After Neoadjuvant Chemotherapy. Takahashi, Maiko; Jinno, Hiromitsu; Hayashida, Tetsu; Sakata, Michio; Asakura, Keiko; Kitagawa, Yuko // World Journal of Surgery;Dec2012, Vol. 36 Issue 12, p2847 

    Background: Neoadjuvant chemotherapy (NAC) is the standard treatment for locally advanced breast cancer. It is now being used to treat operable breast cancer to facilitate breast-conserving surgery, but the accuracy of sentinel lymph node biopsy (SLNB) in breast cancer patients receiving NAC...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics